Peter Wild Selected Research

Peter Wild Research Topics

Disease

37	Neoplasms (Cancer) 11/2021 - 01/2003
20	Prostatic Neoplasms (Prostate Cancer) 09/2022 - 11/2008
7	Breast Neoplasms (Breast Cancer) 05/2018 - 12/2005
6	Neoplasm Metastasis (Metastasis) 01/2021 - 06/2010
6	Infections 12/2020 - 04/2007
6	Urinary Bladder Neoplasms (Bladder Cancer) 01/2020 - 04/2004
6	Melanoma (Melanoma, Malignant) 12/2013 - 11/2004
5	Carcinoma (Carcinomatosis) 09/2022 - 11/2007
4	Margins of Excision 01/2021 - 01/2017
4	Hypoxia (Hypoxemia) 01/2017 - 06/2014
4	Hepatocellular Carcinoma (Hepatoma) 06/2014 - 05/2009
3	Disease Progression 04/2013 - 02/2012
3	Cysts 08/2009 - 04/2003
2	Inflammation (Inflammations) 01/2020 - 07/2015
2	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 05/2013
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2018 - 01/2010
1	Urinary Bladder Neck Obstruction (Bladder Neck Obstruction) 09/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2019
1	Oncogenic osteomalacia 01/2014
1	Gastroenteritis 01/2014
1	Prostatic Intraepithelial Neoplasia 04/2011

Drug/Important Bio-Agent (IBA)

21	Proteins (Proteins, Gene)FDA Link 01/2019 - 04/2003
15	Biomarkers (Surrogate Marker)IBA 01/2020 - 05/2009
4	Messenger RNA (mRNA)IBA 03/2011 - 12/2005
3	Prostate-Specific Antigen (Semenogelase)IBA 01/2021 - 11/2008
3	Transcription Factors (Transcription Factor)IBA 01/2017 - 01/2009
3	AndrogensIBA 10/2014 - 04/2011
3	DNA (Deoxyribonucleic Acid)IBA 12/2013 - 04/2007
2	Metalloproteases (Metalloproteinases)IBA 11/2021 - 11/2008
2	Biological ProductsIBA 01/2019 - 01/2019
2	ParaffinIBA 05/2018 - 08/2010
2	Formaldehyde (Formol)FDA Link 05/2018 - 08/2010
2	Insulin-Like Growth Factor II (Somatomedin A)IBA 01/2017 - 06/2010
2	EnzymesIBA 07/2015 - 12/2013
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2014 - 02/2013
2	Hormones (Hormone)IBA 10/2014 - 02/2012
2	SteroidsIBA 10/2014 - 02/2012
2	Cadherins (E-Cadherin)IBA 06/2014 - 01/2009
2	Choline (Choline Chloride)IBA 10/2012 - 08/2012
2	CytokinesIBA 04/2012 - 03/2011
2	WD repeat containing planar cell polarity effectorIBA 06/2011 - 04/2004
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 02/2011 - 01/2010
2	TensinsIBA 02/2011 - 01/2010
2	Carrier Proteins (Binding Protein)IBA 06/2010 - 09/2005
2	karyopherin alpha 2IBA 09/2008 - 11/2007
1	isopropyl cyanoacrylateIBA 09/2022
1	Docetaxel (Taxotere)FDA Link 11/2021
1	Matrix Metalloproteinases (MMPs)IBA 11/2021
1	AntigensIBA 12/2020
1	Angiopoietin-Like Protein 2IBA 01/2020
1	enzalutamideIBA 01/2020
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2020
1	Calcibiotic Root Canal SealerIBA 01/2019
1	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2019
1	SpectrinIBA 01/2019
1	MutL Protein Homolog 1IBA 01/2019
1	Vascular Endothelial Growth Factor DIBA 01/2018
1	Insulin ReceptorIBA 01/2017
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2017
1	LigandsIBA 01/2017
1	LipidsIBA 01/2017
1	LDL CholesterolIBA 01/2017
1	Peptide Initiation Factors (Initiation Factor)IBA 07/2015
1	eIF-5A2IBA 07/2015
1	deoxyhypusine synthaseIBA 07/2015
1	deoxyhypusine hydroxylaseIBA 07/2015
1	Protein Isoforms (Isoforms)IBA 07/2015
1	hypusineIBA 07/2015
1	MyoglobinIBA 10/2014
1	Oxygen (Dioxygen)IBA 10/2014
1	Androgen Receptors (Androgen Receptor)IBA 10/2014
1	S-Adenosylmethionine (Ademetionine)IBA 06/2014
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 06/2014
1	Hypoxia-Inducible Factor 1IBA 06/2014
1	somatostatin receptor 2IBA 01/2014
1	PeriostinIBA 01/2014
1	Viral ProteinsIBA 01/2014
1	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2014
1	UbiquitinIBA 12/2013
1	HydrolasesIBA 12/2013
1	Mitogen-Activated Protein KinasesIBA 12/2013
1	ErbB Receptors (EGF Receptor)IBA 05/2013
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 02/2013
1	CD13 Antigens (Alanine Aminopeptidase)IBA 04/2012
1	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 02/2012
1	ProteomeIBA 12/2011
1	SerpinsIBA 06/2011
1	CalciumIBA 04/2011

Therapy/Procedure

10	Prostatectomy (Retropubic Prostatectomy) 01/2021 - 11/2008
9	Therapeutics 01/2021 - 01/2008
5	Drug Therapy (Chemotherapy) 11/2021 - 11/2004
4	Castration 01/2020 - 06/2010
4	Lasers (Laser) 01/2020 - 01/2003
2	Adjuvant Chemotherapy 04/2011 - 08/2010
1	Transurethral Resection of Prostate (TURP) 09/2022
1	Nephrectomy 01/2018
1	Neoadjuvant Therapy 01/2018
1	Radiotherapy 01/2014
1	Treatment Delay 09/2013
1	Conservative Treatment 02/2012